Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Near Real-Time Surveillance to Assess the Safety of the 9-Valent Human Papillomavirus Vaccine.

Donahue JG, Kieke BA, Lewis EM, Weintraub ES, Hanson KE, McClure DL, Vickers ER, Gee J, Daley MF, DeStefano F, Hechter RC, Jackson LA, Klein NP, Naleway AL, Nelson JC, Belongia EA.

Pediatrics. 2019 Dec;144(6). pii: e20191808. doi: 10.1542/peds.2019-1808. Epub 2019 Nov 18.

PMID:
31740498
2.

Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15.

Donahue JG, Kieke BA, King JP, Mascola MA, Shimabukuro TT, DeStefano F, Hanson KE, McClure DL, Olaiya O, Glanz JM, Hechter RC, Irving SA, Jackson LA, Klein NP, Naleway AL, Weintraub ES, Belongia EA.

Vaccine. 2019 Oct 16;37(44):6673-6681. doi: 10.1016/j.vaccine.2019.09.035. Epub 2019 Sep 17.

3.

Alcohol and drug use, partner PrEP use and STI prevalence among people with HIV.

Hojilla JC, Marcus J, Volk JE, Leyden W, Hare CB, Hechter RC, Edelman EJ, Silverberg M, Satre DD.

Sex Transm Infect. 2019 Aug 23. pii: sextrans-2019-054049. doi: 10.1136/sextrans-2019-054049. [Epub ahead of print]

PMID:
31444278
4.

Vaccine safety in HIV-infected adults within the Vaccine Safety Datalink Project.

Hechter RC, Qian L, Tartof SY, Sy LS, Klein NP, Weintraub E, Mercado C, Naleway A, McLean HQ, Jacobsen SJ.

Vaccine. 2019 May 31;37(25):3296-3302. doi: 10.1016/j.vaccine.2019.04.080. Epub 2019 May 4.

5.

Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and drug treatment initiation and engagement among people living with the human immunodeficiency virus (HIV) and patients without an HIV diagnosis.

Hechter RC, Horberg MA, Weisner C, Campbell CI, Contreras R, Chen LH, Yarborough BJH, Lapham GT, Haller IV, Ahmedani BK, Binswanger IA, Kline-Simon AH, Satre DD.

Subst Abus. 2019;40(3):302-310. doi: 10.1080/08897077.2019.1580239. Epub 2019 Mar 25.

PMID:
30908174
6.

Patient characteristics associated with treatment initiation and engagement among individuals diagnosed with alcohol and other drug use disorders in emergency department and primary care settings.

Kline-Simon AH, Stumbo SP, Campbell CI, Binswanger IA, Weisner C, Haller IV, Hechter RC, Ahmedani BK, Lapham GT, Loree AM, Sterling SA, Yarborough BJH.

Subst Abus. 2019;40(3):278-284. doi: 10.1080/08897077.2018.1547812. Epub 2019 Jan 31.

PMID:
30702983
7.

Psychiatric comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and other drug treatment initiation and engagement across 7 health care systems.

Loree AM, Yeh HH, Satre DD, Kline-Simon AH, Yarborough BJH, Haller IV, Campbell CI, Lapham GT, Hechter RC, Binswanger IA, Weisner C, Ahmedani BK.

Subst Abus. 2019;40(3):311-317. doi: 10.1080/08897077.2018.1545727. Epub 2019 Jan 25.

PMID:
30681938
8.

Predictors of Healthcare Effectiveness Data and Information Set (HEDIS) treatment initiation and engagement among patients with opioid use disorder across 7 health systems.

Campbell CI, Weisner C, Binswanger IA, Lapham GT, Ahmedani BK, Yarborough BJH, Haller IV, Altschuler A, Hechter RC, Loree AM, Kline-Simon AH.

Subst Abus. 2019;40(3):328-334. doi: 10.1080/08897077.2018.1545729. Epub 2019 Jan 24.

9.

Factors associated with Healthcare Effectiveness Data and Information Set (HEDIS) alcohol and other drug measure performance in 2014-2015.

Weisner C, Campbell CI, Altschuler A, Yarborough BJH, Lapham GT, Binswanger IA, Hechter RC, Ahmedani BK, Haller IV, Sterling SA, McCarty D, Satre DD, Kline-Simon AH.

Subst Abus. 2019;40(3):318-327. doi: 10.1080/08897077.2018.1545728. Epub 2019 Jan 24.

PMID:
30676915
10.

The association between medical comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of treatment initiation and engagement for alcohol and other drug use disorders.

Binswanger IA, Carroll NM, Ahmedani BK, Campbell CI, Haller IV, Hechter RC, McNeely J, Yarborough BJH, Kline-Simon AH, Satre DD, Weisner C, Lapham GT.

Subst Abus. 2019;40(3):292-301. doi: 10.1080/08897077.2018.1545726. Epub 2019 Jan 24.

PMID:
30676892
11.

The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7 US health systems.

Lapham GT, Campbell CI, Yarborough BJH, Hechter RC, Ahmedani BK, Haller IV, Kline-Simon AH, Satre DD, Loree AM, Weisner C, Binswanger IA.

Subst Abus. 2019;40(3):268-277. doi: 10.1080/08897077.2018.1544964. Epub 2019 Jan 18.

12.

Safety of Influenza Vaccination Administered During Hospitalization.

Tartof SY, Qian L, Liu IA, Tseng HF, Sy LS, Hechter RC, Lewin BJ, Jacobsen SJ.

Mayo Clin Proc. 2019 Mar;94(3):397-407. doi: 10.1016/j.mayocp.2018.11.024. Epub 2019 Jan 8.

PMID:
30635116
13.

Effect of an Electronic Alert on Targeted HIV Testing Among High-Risk Populations.

Hechter RC, Bider-Canfield Z, Towner W.

Perm J. 2018;22:18-015. doi: 10.7812/TPP/18-015.

14.

Impact of an electronic medical record reminder on hepatitis B vaccine initiation and completion rates among insured adults with diabetes mellitus.

Hechter RC, Qian L, Luo Y, Ling Grant DS, Baxter R, Klein NP, Valdez Nunley K, Aukes L, Hogea C, Krishnarajah G, Patterson BJ, Im TM, Tseng HF.

Vaccine. 2019 Jan 3;37(1):195-201. doi: 10.1016/j.vaccine.2018.06.035. Epub 2018 Jun 27.

PMID:
29958736
15.

Infant Hospitalizations and Mortality After Maternal Vaccination.

Sukumaran L, McCarthy NL, Kharbanda EO, Vazquez-Benitez G, Lipkind HS, Jackson L, Klein NP, Naleway AL, McClure DL, Hechter RC, Kawai AT, Glanz JM, Weintraub ES.

Pediatrics. 2018 Mar;141(3). pii: e20173310. doi: 10.1542/peds.2017-3310. Epub 2018 Feb 20.

16.

Maternal and Infant Outcomes After Human Papillomavirus Vaccination in the Periconceptional Period or During Pregnancy.

Lipkind HS, Vazquez-Benitez G, Nordin JD, Romitti PA, Naleway AL, Klein NP, Hechter RC, Jackson ML, Hambidge SJ, Lee GM, Sukumaran L, Kharbanda EO.

Obstet Gynecol. 2017 Sep;130(3):599-608. doi: 10.1097/AOG.0000000000002191.

17.

Impact of the change of copay policy in Medicare Part D on zoster vaccine uptake among Medicare beneficiaries in a managed care organization.

Hechter RC, Qian L, Yan S, Luo Y, Krishnarajah G, Tseng HF.

BMC Health Serv Res. 2017 Jul 21;17(1):503. doi: 10.1186/s12913-017-2441-7.

18.

Safety of Quadrivalent Meningococcal Conjugate Vaccine in Children 2-10 Years.

Tartof SY, Sy LS, Ackerson BK, Hechter RC, Haag M, Slezak JM, Luo Y, Fischetti CA, Takhar HS, Miao Y, Solano Z, Jacobsen SJ, Tseng HF.

Pediatr Infect Dis J. 2017 Nov;36(11):1087-1092. doi: 10.1097/INF.0000000000001696.

PMID:
28719502
19.

Safety of Quadrivalent Meningococcal Conjugate Vaccine in 11- to 21-Year-Olds.

Tseng HF, Sy LS, Ackerson BK, Hechter RC, Tartof SY, Haag M, Slezak JM, Luo Y, Fischetti CA, Takhar HS, Miao Y, Cunnington M, Solano Z, Jacobsen SJ.

Pediatrics. 2017 Jan;139(1). pii: e20162084. doi: 10.1542/peds.2016-2084.

20.

Safety of Seasonal Influenza Vaccination in Hospitalized Surgical Patients: A Cohort Study.

Tartof SY, Qian L, Rieg GK, Yu KC, Sy LS, Tseng HF, Hechter RC, Jacobsen SJ.

Ann Intern Med. 2016 May 3;164(9):593-9. doi: 10.7326/M15-1667. Epub 2016 Mar 15.

PMID:
26974053
21.

Declining Effectiveness of Herpes Zoster Vaccine in Adults Aged ≥60 Years.

Tseng HF, Harpaz R, Luo Y, Hales CM, Sy LS, Tartof SY, Bialek S, Hechter RC, Jacobsen SJ.

J Infect Dis. 2016 Jun 15;213(12):1872-5. doi: 10.1093/infdis/jiw047. Epub 2016 Feb 9.

PMID:
26908728
22.

Effectiveness of Herpes Zoster Vaccine in Patients 60 Years and Older With End-stage Renal Disease.

Tseng HF, Luo Y, Shi J, Sy LS, Tartof SY, Sim JJ, Hechter RC, Jacobsen SJ.

Clin Infect Dis. 2016 Feb 15;62(4):462-7. doi: 10.1093/cid/civ930. Epub 2015 Dec 14.

PMID:
26671505
23.

Quadrivalent Human Papillomavirus Vaccine Initiation in Boys Before and Since Routine Use: Southern California, 2009-2013.

Hechter RC, Chao CR, Sidell MA, Sy LS, Ackerson BK, Slezak JM, Patel NJ, Tseng HF, Jacobsen SJ.

Am J Public Health. 2015 Dec;105(12):2549-56. doi: 10.2105/AJPH.2015.302840. Epub 2015 Oct 15.

24.

Unmasking in an observational vaccine safety study: Using type 2 diabetes mellitus as an example.

Ackerson BK, Sy LS, Slezak J, Chao CR, Hechter RC, Takhar HS, Jacobsen SJ.

Vaccine. 2015 Nov 17;33(46):6224-6. doi: 10.1016/j.vaccine.2015.09.080. Epub 2015 Oct 9.

PMID:
26440925
25.

Safety of measles-containing vaccines in 1-year-old children.

Klein NP, Lewis E, Fireman B, Hambidge SJ, Naleway A, Nelson JC, Belongia EA, Yih WK, Nordin JD, Hechter RC, Weintraub E, Baxter R.

Pediatrics. 2015 Feb;135(2):e321-9. doi: 10.1542/peds.2014-1822. Epub 2015 Jan 5.

26.

Inpatient admission for febrile seizure and subsequent outcomes do not differ in children with vaccine-associated versus non-vaccine associated febrile seizures.

Tartof SY, Tseng HF, Liu IL, Qian L, Sy LS, Hechter RC, Marcy SM, Jacobsen SJ.

Vaccine. 2014 Nov 12;32(48):6408-14. doi: 10.1016/j.vaccine.2014.09.055. Epub 2014 Oct 5.

PMID:
25285882
27.

Exploring the risk factors for vaccine-associated and non-vaccine associated febrile seizures in a large pediatric cohort.

Tartof SY, Tseng HF, Liu AL, Qian L, Sy LS, Hechter RC, Marcy SM, Jacobsen SJ.

Vaccine. 2014 May 7;32(22):2574-81. doi: 10.1016/j.vaccine.2014.03.044. Epub 2014 Mar 25.

PMID:
24674662
28.

Hepatitis B testing and vaccination among adults with sexually transmitted infections in a large managed care organization.

Hechter RC, Jacobsen SJ, Luo Y, Nomura JH, Towner WJ, Tartof SY, Tseng HF.

Clin Infect Dis. 2014 Jun;58(12):1739-45. doi: 10.1093/cid/ciu103. Epub 2014 Feb 25.

PMID:
24571863
29.

Trends and disparity in zoster vaccine uptake in a managed care population.

Hechter RC, Tartof SY, Jacobsen SJ, Smith N, Tseng HF.

Vaccine. 2013 Sep 23;31(41):4564-8. doi: 10.1016/j.vaccine.2013.07.053. Epub 2013 Aug 5.

PMID:
23928461
30.

Quadrivalent human papillomavirus vaccine uptake in adolescent boys and maternal utilization of preventive care and history of sexually transmitted infections.

Hechter RC, Chao C, Sy LS, Ackerson BK, Slezak JM, Sidell MA, Jacobsen SJ.

Am J Public Health. 2013 Sep;103(9):e63-8. doi: 10.2105/AJPH.2013.301495. Epub 2013 Jul 18.

31.

The accuracy and trends of smoking history documentation in electronic medical records in a large managed care organization.

Chen LH, Quinn V, Xu L, Gould MK, Jacobsen SJ, Koebnick C, Reynolds K, Hechter RC, Chao CR.

Subst Use Misuse. 2013 Jun;48(9):731-42. doi: 10.3109/10826084.2013.787095. Epub 2013 Apr 26.

PMID:
23621678
32.

Secular trends in diagnostic code density in electronic healthcare data from health care systems in the Vaccine Safety Datalink project.

Hechter RC, Qian L, Sy LS, Greene SK, Weintraub ES, Naleway AL, Rowhani-Rahbar A, Donahue JG, Daley MF, Vazquez-Benitez G, Lugg MM, Jacobsen SJ.

Vaccine. 2013 Feb 4;31(7):1080-5. doi: 10.1016/j.vaccine.2012.12.030. Epub 2012 Dec 23.

PMID:
23267842
33.

Clinical effectiveness of pneumococcal polysaccharide vaccine in men: California Men's Health Study.

Hechter RC, Chao C, Jacobsen SJ, Slezak JM, Quinn VP, Van Den Eeden SK, Tseng HF.

Vaccine. 2012 Aug 17;30(38):5625-30. doi: 10.1016/j.vaccine.2012.06.085. Epub 2012 Jul 10.

PMID:
22789510
34.

Herpes simplex virus type 2 (HSV-2) as a coronary atherosclerosis risk factor in HIV-infected men: multicenter AIDS cohort study.

Hechter RC, Budoff M, Hodis HN, Rinaldo CR, Jenkins FJ, Jacobson LP, Kingsley LA, Taiwo B, Post WS, Margolick JB, Detels R.

Atherosclerosis. 2012 Aug;223(2):433-6. doi: 10.1016/j.atherosclerosis.2012.03.002. Epub 2012 Mar 14.

35.

Correlates for second-dose varicella vaccination in school-age children in a managed care organization in California.

Hechter RC, Chao C, Li Q, Jacobsen SJ, Tseng HF.

Pediatr Infect Dis J. 2012 Jul;31(7):752-5. doi: 10.1097/INF.0b013e3182567d1a.

PMID:
22466321
36.

Second-dose varicella vaccination coverage in children and adolescents in a managed care organization in California, 2006-2009.

Hechter RC, Chao C, Li Q, Jacobsen SJ, Tseng HF.

Pediatr Infect Dis J. 2011 Aug;30(8):705-7. doi: 10.1097/INF.0b013e31820eae6a.

PMID:
21283048
37.

Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals.

Kalantar-Zadeh K, Shah A, Duong U, Hechter RC, Dukkipati R, Kovesdy CP.

Kidney Int Suppl. 2010 Aug;(117):S10-21. doi: 10.1038/ki.2010.189. Review.

Supplemental Content

Loading ...
Support Center